513 results on '"Colomba C"'
Search Results
202. Leishmaniosi viscerale e sindrome di Down:descrizione di un caso clinico
- Author
-
COLOMBA, Claudia, SAPORITO, Laura, INFURNARI, Laura, TITONE LANZA DI SCALEA, Lucina, GIORDANO S, COLOMBA C, SAPORITO L, GIORDANO S, INFURNARI L, and TITONE L
- Published
- 2005
203. Confronto di metodiche per la diagnosi di infezione da norovirus in pazienti pediatrici con gastroenterite
- Author
-
GIAMMANCO, Giovanni, DE GRAZIA, Simona, RAMIREZ, Stefania, COLOMBA, Claudia, ARISTA, Serenella, GIAMMANCO GM, DE GRAZIA S, RAMIREZ S, COLOMBA C, and ARISTA S
- Published
- 2005
204. Variability of G2 Rotavirus strains infecting the infantile population in Palermo, Italy, over a period of 12 years (1993-2004)
- Author
-
DE GRAZIA, Simona, GIAMMANCO, Giovanni, COLOMBA, Claudia, LO BIUNDO, Concetta, ARISTA, Serenella, ITURRIZA GMARA M, MARTELLA, V, DE GRAZIA S, GIAMMANCO GM, ITURRIZA-GMARA M, COLOMBA C, MARTELLA, LO BIUNDO C, and ARISTA S
- Published
- 2005
205. Caratteristiche cliniche e di laboratorio di 415 bambini siciliani con febbre bottonosa del Mediterraneo (FBM)
- Author
-
COLOMBA, Claudia, SAPORITO, Laura, RUBINO, Raffaella, INFURNARI, Laura, TITONE LANZA DI SCALEA, Lucina, COLOMBA C, SAPORITO L, RUBINO R, INFURNARI L, and TITONE L
- Published
- 2005
206. Attualità in tema di gastroenteriti virali infantili
- Author
-
SIMONA DE GRAZIA, Claudia Colomba, Antonio Cascio, Giammanco, Giovanni M., DE GRAZIA, S., Colomba, C., Cascio, A., and Giammanco, G.
- Subjects
Settore MED/07 - Microbiologia E Microbiologia Clinica ,Settore MED/17 - Malattie Infettive ,gastroenteriti - Abstract
Acute gastroenteritis is one of the most common diseases in humans worldwide. Viruses are recognized as important causes of this disease, particularly in children. Rotavirus is the most common cause of severe diarrhea in children under 5 years of age. Astrovirus, calicivirus and enteric adenovirus are also important etiologic agents of acute gastroenteritis. Other viruses, such as toroviruses and picobirnaviruses are increasingly being identified as causative agents of diarrhea. In recent years, the availability of diagnostic tests, mainly immunoassays or molecular biology techniques, has increased our understanding of this group of viruses. The future development of a safe and highly effective vaccine against rotavirus could prevent, at least, cases of severe diarrhea and reduce mortality from this disease.
- Published
- 2004
207. Un caso di FBM neonatale in corso di un outbrek familiare
- Author
-
COLOMBA, Claudia, SCARLATA, Francesco, TITONE LANZA DI SCALEA, Lucina, FRASCA POLARA V, LEITAO R, COLOMBA C, SCARLATA F, FRASCA POLARA V, LEITAO R, and TITONE L
- Published
- 2004
208. A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: the Italian experience
- Author
-
Camilla Aiassa, Lucio Di Martino, Raffaella Giacchino, Chiara Iaria, Salvatore Giordano, Paolo Occorsio, Marina Gramiccia, Claudia Colomba, Anna Rita Gigliotti, Catania S, Valentina Frasca Polara, Luigi Gradoni, Antonio Cascio, Spinello Antinori, Lucina Titone, Cascio, A., Di Martino, L., Occorsio, P., Giacchino, R., Catania, S., Gigliotti, A., Aiassa, C., Iaria, C., Giordano, S., Colomba, C., Frasca Polara, V., TITONE LANZA DI SCALEA, L., Gradoni, L., Gramiccia, M., and Antinori, S.
- Subjects
Male ,Microbiology (medical) ,medicine.medical_specialty ,Adolescent ,Fever ,Antiprotozoal Agents ,Fluorescent Antibody Technique ,Nutritional Status ,italy ,leishmania infantum ,therapy ,Bone Marrow ,Recurrence ,Amphotericin B ,Internal medicine ,medicine ,Humans ,Pharmacology (medical) ,Child ,Adverse effect ,leishmaniasis ,Retrospective Studies ,Pharmacology ,Drug Carriers ,biology ,business.industry ,Infant ,Retrospective cohort study ,Leishmaniasis ,medicine.disease ,biology.organism_classification ,Surgery ,Regimen ,Treatment Outcome ,Infectious Diseases ,Visceral leishmaniasis ,Italy ,El Niño ,Child, Preschool ,Liposomes ,Leishmaniasis, Visceral ,Female ,Leishmania infantum ,business ,medicine.drug - Abstract
Objectives To evaluate in a retrospective analysis the efficacy and safety of a 6 day course of liposomal amphotericin B (L-AmB) in infantile cases of Mediterranean visceral leishmaniasis (VL) diagnosed over a 10 year period in Italy. Patients and methods Patients included were diagnosed as having VL consecutively admitted from December 1992 to December 2001 at four main referral children's hospitals in Italy and treated with six intravenous doses of 3 mg/kg L-AmB given on days 1-5 and 10 (a total dose of 18 mg/kg). Demographic data, nutritional status, underlying diseases, clinical and laboratory findings, and therapy outcome were considered. Results A total of 164 HIV-negative children (median age 1.6 years; range 4 months to 14 years) were enrolled. All patients were initially cured by the given treatment, and did not present adverse events related to drug infusion. Seven patients (4.3%) had a clinical and parasitological relapse 3-15 months after therapy. All relapses were successfully retreated with 3 mg/kg L-AmB for 10 consecutive days (a total dose of 30 mg/kg). Conclusions This study highlights the efficacy (>95%) and safety of the six dose L-AmB regimen and validates it as a first-line treatment for Mediterranean VL in children.
- Published
- 2004
209. Parassitosi emergente: la sindrome da LMV
- Author
-
SCARLATA, Francesco, CURRERI, Salvatore, COLOMBA, Claudia, TITONE LANZA DI SCALEA, Lucina, GIORDANO S, SCARLATA F, CURRERI SR, GIORDANO S, COLOMBA C, and TITONE L
- Published
- 2004
210. Variabilità genetica di VP7 e VP4 in Rotavirus G4 in bambini palermitani
- Author
-
ARISTA, Serenella, GIAMMANCO, Giovanni, DE GRAZIA, Simona, MARTELLA V, COLOMBA, Claudia, ARISTA S, GIAMMANCO GM, DE GRAZIA S, MARTELLA V, and COLOMBA C
- Published
- 2004
211. [Macrolides in the treatment of children with Mediterranean spotted fever]
- Author
-
Antonio Cascio, Claudia Colomba, Cascio, A., and Colomba, C.
- Subjects
Male ,Adolescent ,Infant ,Azithromycin ,Boutonneuse Fever ,Anti-Bacterial Agents ,Chloramphenicol ,Treatment Outcome ,Italy ,Tetracyclines ,Child, Preschool ,Clarithromycin ,Humans ,Female ,Macrolides ,Child ,Sicily ,Mediterranean spotted fever, macrolides ,Randomized Controlled Trials as Topic - Abstract
Till now there is not a gold standard therapy for Mediterranean spotted fever (MSF) in children. Standard treatment for MSF is the administration of tetracycline or chloramphenicol, however both these drugs can cause significant adverse effects in children (tetracyclines can cause staining of teeth, chloramphenicol severe hematological adverse events such as aplastic anemia, gray baby syndrome and hemolytic anemia in patients with the Mediterranean form of G6PD deficiency). We conducted two randomized clinical trials; the first compared clarithromycin versus chloramphenicol: mean time to defervescence was 36.7 +/- 18.1 h in the clarithromycin group and 47.1+/- 21.9 h in the chloramphenicol group (P= 0.047). The second trial compared clarithromycin versus azithromycin and did not show any statistically significant difference: mean time to defervescence was 46.2 +/- 36.4 h in the clarithromycin group and 39.3 +/- 31.3 h in the azithromycin group (P= 0.34). On the basis of these studies we think that clarithromycin and azithromycin could constitute an acceptable alternative to chloramphenicol and to tetracyclines for the treatment of MSF in children
- Published
- 2003
212. Childhood Mediterranean visceral leishmaniasis
- Author
-
Antonio Cascio, Claudia Colomba, Cascio, A., and Colomba, C.
- Subjects
Mediterranean Region ,Infant, Newborn ,Humans ,Infant ,Leishmaniasis, Visceral ,leishmaniasis - Abstract
Visceral leishmaniasis (VL) is endemic in areas bordering the Mediterranean Sea (Spain, Italy, France, Greece, Morocco, Tunisia) where it is caused by Leishmania infantum and it is transmitted by the bite of hematophagous sandfly belonging to Phlebotomus spp.; dog constitutes the main reservoir of the infection. In comparison with the past, when VL was typically observed more frequently in children, the current ratio of childhood to adult cases is approximately 1:1. The onset of the disease is characterized by a non-specific initial symptomatology; fever, pallor and splenomegaly are always present. Pancytopenia is present very often; the laboratory diagnosis is established by serological tests (indirect fluorescent-antibody assay, immunoassay test, indirect hemagglutination assay) and by demonstration of Leishmania parasites by microscopy, culture or polymerase chain reaction (PCR) in the bone marrow aspirates. The use of PCR performed on peripheral blood has been reported to be highly sensitive for the diagnosis and the follow up of children with VL. Pentavalent antimonial drugs have been used for many decades as standard treatment for VL; in Italy liposomal amphotericin B (AmBisome) is nowadays considered the first-line treatment for VL.
- Published
- 2003
213. Treatment of human brucellosis with rifampin plus minocycline
- Author
-
Giordano S, Spinello Antinori, Lucina Titone, Scarlata F, Claudia Colomba, Antonio Cascio, Cascio, A., Scarlata, F., Giordano, S., Antinori, S., Colomba, C., and TITONE LANZA DI SCALEA, L.
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Minocycline ,Risk Assessment ,Drug Administration Schedule ,Pharmacotherapy ,Recurrence ,Internal medicine ,medicine ,Humans ,Pharmacology (medical) ,Child ,Infusions, Intravenous ,Adverse effect ,Aged ,Retrospective Studies ,Antibacterial agent ,Aged, 80 and over ,Pharmacology ,Chemotherapy ,Dose-Response Relationship, Drug ,business.industry ,Retrospective cohort study ,Middle Aged ,Brucella ,Surgery ,Treatment Outcome ,Infectious Diseases ,Italy ,Oncology ,Tolerability ,Child, Preschool ,brucellosis ,Drug Therapy, Combination ,Female ,Rifampin ,business ,Rifampicin ,Follow-Up Studies ,medicine.drug - Abstract
In order to evaluate the efficacy and tolerability of a high intravenous dose of rifampin plus oral minocycline (administered daily for 3 weeks) for the treatment of acute brucellosis, we retrospectively reviewed the outcome of 239 consecutive patients (135 adults and 104 children) diagnosed and treated over a 17-year period in Italy. The combination used resulted in 100% response and a relapse rate lower than 2%. Fifty-two (30 adults and 22 children) (29.8%) complained of mild adverse effects including an increase in aspartate aminotransferase (>250 IU) observed in 12 cases and considered related to rifampin and in 11 cases a reversible hyperpigmentation of the tongue attributed to minocycline. A randomized prospective comparative study should be performed to confirm our encouraging results.
- Published
- 2003
214. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases
- Author
-
Antonio Cascio, Spinello Antinori, Claudia Colomba, Lucina Titone, David L. Paterson, M. Orobello, Cascio, A., Colomba, C., Antinori, S., Orobello, M., Paterson, D., and TITONE LANZA DI SCALEA, L.
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,Anemia ,Meglumine antimoniate ,Antiprotozoal Agents ,children leishmaniosis ,Meglumine ,Recurrence ,Amphotericin B ,Internal medicine ,Epidemiology ,Organometallic Compounds ,medicine ,Animals ,Humans ,Child ,Sicily ,Retrospective Studies ,Leishmania ,Meglumine Antimoniate ,Leukopenia ,business.industry ,Infant ,Retrospective cohort study ,Leishmaniasis ,General Medicine ,medicine.disease ,Nutrition Disorders ,Surgery ,Treatment Outcome ,Infectious Diseases ,Visceral leishmaniasis ,Child, Preschool ,Leishmaniasis, Visceral ,medicine.symptom ,business ,medicine.drug - Abstract
The clinical and epidemiological characteristics of 111 consecutive cases of visceral leishmaniasis identified from 1980 to 2000 in a Sicilian pediatric hospital were analyzed retrospectively. The mean age of the patients was 1.7 years. All children were HIV negative, but 15% were severely malnourished. Fever and splenomegaly were present in all cases and hepatomegaly in 101 (90.1%) cases. Thrombocytopenia and anemia were both observed in 78 (70.2%) cases and leukopenia in 47 (42.3%) cases. A bone marrow aspirate was obtained in all cases; Leishmania amastigotes were detected in 89 (80.2%) cases. Initial treatment consisted of meglumine antimoniate in 99 (89.2%) patients and amphotericin B in 12 (10.8%) patients. Only two children treated with meglumine antimoniate relapsed. The findings highlight the differences between the cases of visceral leishmaniasis observed in the Mediterranean basin and those observed in other regions. The use of the term "Mediterranean visceral leishmaniasis", rather than the term "kala-azar", is proposed for cases observed in the Mediterranean area.
- Published
- 2002
215. Polymerase chain reaction in the diagnosis and prognosis of Mediterranean visceral leishmaniasis in immunocompetent children
- Author
-
Marina Gramiccia, Sara Calattini, Morena Galazzi, Antonio Cascio, Massimo Pizzuto, Mario Corbellino, Chiara Scalamogna, Lucina Titone, Claudia Colomba, Spinello Antinori, Romina Camilli, Cascio, A., Calattini, S., Colomba, C., Scalamogna, C., Galazzi, M., Pizzuto, M., Camilli, R., Gramiccia, M., TITONE LANZA DI SCALEA, L., Corbellino, M., and Antinori, S.
- Subjects
Hepatosplenomegaly ,Polymerase Chain Reaction ,law.invention ,Serology ,law ,medicine ,Prospective Studies ,Polymerase chain reaction Mediterranean visceral leishmaniasis ,Prospective cohort study ,Polymerase chain reaction ,biology ,business.industry ,Leishmania ,biology.organism_classification ,medicine.disease ,Prognosis ,Pancytopenia ,Visceral leishmaniasis ,medicine.anatomical_structure ,Pediatrics, Perinatology and Child Health ,Immunology ,Leishmaniasis, Visceral ,Bone marrow ,medicine.symptom ,business - Abstract
Objective. To assess the usefulness of a polymerase chain reaction (PCR) assay amplifying the small subunit rRNA coding region of Leishmania species performed on peripheral blood (PB) and bone marrow (BM) aspirates for the diagnosis and follow-up of visceral leishmaniasis (VL) in children living in the Mediterranean basin. Design. A prospective study was conducted on children consecutively hospitalized over a 1-year period at our Infectious Diseases Department in Sicily (Italy) presenting with fever, hepatosplenomegaly, and/or pancytopenia and a positive Leishmania serology (≥1:40). Results. Among the 14 patients hospitalized with signs and symptoms suggestive of the disease and a positive serology, we identified 10 cases of Mediterranean VL. PCR performed on PB and BM aspirates was positive in all cases and concordant with microscopy and/or culture performed on BM. Leishmania DNA was cleared from PB a median of 6 days after the start of treatment; during follow-up (median: 9 months; range: 6–12 months) 1 child relapsed. In this case, BM PCR remained positive with rapid reappearance of a positive signal also in PB. Conclusions. PB PCR allows a rapid and noninvasive parasitologic diagnosis of Mediterranean VL among immunocompetent children and is at least as sensitive as a diagnosis made on the basis of BM aspirates. The lack of disappearance from BM and the reappearance of positive PCR on PB is predictive of clinical relapse. Qualitative and semiquantitative PCR may be the standard method for monitoring response to therapy in immunocompetent children.
- Published
- 2002
216. Efficacy and safety of clarithromycin as treatment for Mediterranean spotted fever in children: a randomized controlled trial
- Author
-
Antonio Cascio, Domenico Di Rosa, Claudia Colomba, L Salsa, Lucio Di Martino, Lucina Titone, Cascio, A., Colomba, C., Di Rosa, D., Salsa, L., di Martino, L., and TITONE LANZA DI SCALEA, L.
- Subjects
Microbiology (medical) ,Male ,medicine.medical_specialty ,Boutonneuse Fever ,Gastroenterology ,law.invention ,Randomized controlled trial ,Oral administration ,law ,Clarithromycin ,Internal medicine ,medicine ,Humans ,Child ,Antibacterial agent ,clarithromycin Mediterranean spotted fever ,business.industry ,Chloramphenicol ,medicine.disease ,Spotted fever ,Surgery ,Anti-Bacterial Agents ,Boutonneuse fever ,Infectious Diseases ,Rickettsiosis ,Child, Preschool ,Female ,business ,medicine.drug - Abstract
Fifty-one children with Mediterranean spotted fever (MSF) were randomized to receive either clarithromycin, 15 mg/kg/ day orally in 2 divided doses, or chloramphenicol, 50 mg/ kg/day orally in 4 divided doses, for 7 days. Mean time to defervescence was 36.7 h in the clarithromycin group and 47.1 h in the chloramphenicol group (P = .047). Clarithromycin could be an acceptable therapeutic alternative to chloramphenicol and to tetracyclines for children aged
- Published
- 2001
217. Intestinal protozoa in HIV-infected patients: effect of rifaximin in Cryptosporidium parvum and Blastocystis hominis infections
- Author
-
Amenta, M, Dalle Nogare, ER, Prestileo, TS, Di Lorenzo, F, Fundaro, S, Colomba, A, Ferrieri, A., COLOMBA, Claudia, Amenta, M., Dalle Nogare, E., Colomba, C., Prestileo, T., Di Lorenzo, F., Fundaro, S., Colomba, A., and Ferrieri, A.
- Subjects
rifaximin Cryptosporidium HIV - Abstract
In HIV-1 infected patients severe enteritis and chronic diarrhea are often documented as a consequence of multiple opportunistic infections. We analyzed 48 HIV-1 positive patients for the presence of intestinal pathogenic protozoa. Patients with CD4 > or = 200/mm3 showed a higher prevalence of a single pathogenic protozoa than patients with CD4 < or =200/mm3, who showed the presence of multiple protozoal infections. Patients who proved positive for only a single protozoa, Cryptosporidium or Blastocystis, were also positive, by stool culture, for the presence of Proteus mirabilis (3 samples), Citrobacter freundii (3 samples), Escherichia coli (one sample) or Enterobacter cloacae (one sample). Treatment with rifaximin (600 mg, 3 times a day, for 14 days) was efficacious in resolving the clinical symptoms and clearing protozoan infections in HIV-1 infected patients with CD4 > or = 200/mm3, who presented enteric and systemic symptoms due to Criptosporidium or Blastocystis associated with enteropathogenic bacteria
- Published
- 1999
218. Transient elastography: A non-invasive tool for assessing liver fibrosis in HIV/HCV patients
- Author
-
Giuseppe Montalto, Valentina Li Vecchi, Giovanni Mazzola, Emanuele La Spada, M Mineo, Claudia Colomba, P. Colletti, Paola Di Carlo, Maurizio Soresi, Giovanni Vizzini, Li Vecchi, V, Soresi, M, Colomba, C, Mazzola, G, Colletti, P, Mineo, M, Di Carlo, P, La Spada, E, Vizzini, G, and Montalto, G.
- Subjects
Adult ,Liver Cirrhosis ,Male ,medicine.medical_specialty ,Transient elastography ,Cirrhosis ,Brief Article ,viruses ,Hepacivirus ,Liver fibrosis ,Hepatitis C virus ,Fibrosis evaluation ,HIV Infections ,Comorbidity ,medicine.disease_cause ,Gastroenterology ,Human immunodeficiency virus infection ,Antiretroviral Therapy, Highly Active ,Internal medicine ,medicine ,Humans ,Aspartate Aminotransferases ,biology ,business.industry ,digestive, oral, and skin physiology ,HIV ,Liver fibrosi ,virus diseases ,General Medicine ,Hepatitis C ,Middle Aged ,medicine.disease ,biology.organism_classification ,digestive system diseases ,Aspartate aminotransferase platelet ratio index ,Liver ,Immunology ,Elasticity Imaging Techniques ,RNA, Viral ,Hepatitis C virus infection ,FIB-4 test ,Liver function ,business - Abstract
AIM: To assess the prevalence of advanced liver fibrosis (ALF) in human immunodeficiency virus (HIV), hepatitis C virus (HCV) and HIV/HCV patients using transient elastography, and to identify factors associated with ALF. METHODS: Between September 2008 and October 2009, 71 HIV mono-infected, 57 HIV/HCV co-infected and 53 HCV mono-infected patients on regular follow-up at our Center were enrolled in this study. Alcohol intake, the main parameters of liver function, presence of HCV-RNA, HIV-RNA, duration of highly active anti-retroviral therapy (HAART) and CD4 cell count were recorded. ALF was defined as liver stiffness (LS) ≥ 9.5 kPa. To estimate liver fibrosis (LF) a further 2 reliable biochemical scores, aspartate aminotransferase platelet ratio index (APRI) and FIB-4, were also used. RESULTS: LS values of co-infected patients were higher than in either HIV or HCV mono-infected patients (c2MH = 4, P < 0.04). In fact, LS ≥ 9.5 was significantly higher in co-infected than in HIV and HCV mono-infected patients (c2 = 5, P < 0.03). Also APRI and the FIB-4 index showed more LF in co-infected than in HIV mono-infected patients (P < 0.0001), but not in HCV mono-infected patients. In HIV⁄HCV co-infected patients, the extent of LS was significantly associated with alcohol intake (P < 0.04) and lower CD4+ cell count (P < 0.02). In HCV patients, LS was correlated with alcohol intake (P < 0.001) and cholesterol levels (P < 0.03). Body mass index, diabetes, HCV- and HIV-viremia were not significantly correlated with LS. In addition, 20% of co-infected patients had virologically unsuccessful HAART; in 50% compliance was low, CD4+ levels were < 400 cells/mm3 and LS was > 9.5 kPa. There was no significant correlation between extent of LF and HAART exposure or duration of HAART exposure, in particular with specific dideoxynucleoside analogues. CONCLUSION: ALF was more frequent in co-infected than mono-infected patients. This result correlated with lower CD4 levels. Protective immunological effects of HAART on LF progression outweigh its hepatotoxic effects.
- Published
- 2010
219. Visceral leishmaniasis in a patient with Down syndrome
- Author
-
Patrizia Ajovalasit, Salvatore Giordano, Laura Saporito, Claudia Colomba, Lucina Titone, Laura Infurnari, Colomba, C., Saporito, L., Giordano, S., Infurnari, L., Ajavolasit, P., and TITONE LANZA DI SCALEA, L.
- Subjects
Pathology ,medicine.medical_specialty ,Down syndrome ,Antiprotozoal Agents ,MEDLINE ,Antibodies, Protozoan ,Aneuploidy ,Amphotericin B ,Animals ,Humans ,visceral leishmaniasis ,Medicine ,Protozoal disease ,Leishmania ,business.industry ,Infant ,Leishmaniasis ,medicine.disease ,Pancytopenia ,Dermatology ,Visceral leishmaniasis ,Splenomegaly ,Pediatrics, Perinatology and Child Health ,Leishmaniasis, Visceral ,Down Syndrome ,business ,Trisomy ,Hepatomegaly - Published
- 2005
220. HIV infection with viro-immunological dissociation in a patient with polycystic kidney disease: Candidate for transplantation?
- Author
-
Danilo Di Bona, Antonio Cascio, Marcello Trizzino, Claudia Colomba, Alessandra Mularoni, Claudia Gioè, Colomba, C., Trizzino, M., Gioe', C., Di Bona, D., Mularoni, A., and Cascio, A.
- Subjects
030232 urology & nephrology ,Human immunodeficiency virus (HIV) ,Case Report ,Viro-immunological dissociation ,medicine.disease_cause ,Virological response ,03 medical and health sciences ,0302 clinical medicine ,Polycystic kidney disease ,Lymphopenia ,Medicine ,030212 general & internal medicine ,Stage (cooking) ,Kidney transplantation ,Transplantation ,urogenital system ,business.industry ,HIV ,Infectious Diseases ,virus diseases ,medicine.disease ,Antiretroviral therapy ,Immunology ,business - Abstract
Highlights • Autosomal dominant polycystic kidney disease is the most common among inherited cystic kidney diseases. • Patients with HIV infection are at risk of developing acute kidney injury and chronic kidney disease. • We provide the first report of HIV infection in a patient with polycystic kidney disease. • Lymphopenia should not contraindicate kidney transplantation in patients with HIV infection., Here we describe the case of a HIV-infected patient with polycystic kidney disease and end stage renal diseases not transplantable due to the persistence of a CD4 count
- Full Text
- View/download PDF
221. A case of Brucella endocarditis in association with subclavian artery thrombosis
- Author
-
Claudia Imburgia, Marcello Trizzino, Raffaella Rubino, Lucina Titone, Lucia Siracusa, Francesco Scarlata, Claudia Colomba, Colomba, C., Siracusa, L., Rubino, R., Trizzino, M., Scarlata, F., Imburgia, C., and TITONE LANZA DI SCALEA, L.
- Subjects
Pediatrics ,medicine.medical_specialty ,biology ,business.industry ,Zoonosis ,Brucellosis ,Case Report ,General Medicine ,Brucella ,brucellosi, complicanze, endocardite ,biology.organism_classification ,medicine.disease ,Subclavian artery thrombosis ,Asymptomatic ,Thrombosis ,Surgery ,lcsh:Infectious and parasitic diseases ,medicine ,Endocarditis ,lcsh:RC109-216 ,medicine.symptom ,Sign or Symptom ,business - Abstract
Brucellosis is a common zoonosis, endemic in Mediterranean countries, and caused by bacteria ofBrucellagenus. Brucellosis is a systemic infection and the clinical presentation varies widely from asymptomatic and mild to severe disease. Cardiovascular complications are extremely rare. We present a case of arterial thrombosis in a previously healthy young patient withBrucellaendocarditis. Careful attention must be paid to any sign or symptom of thrombosis in patients affected by brucellosis, regardless of the presence of endocarditis and cardiovascular risk factors.
222. Acalculous cholecystitis in a patient with plasmodium falciparum malaria and cytomegalovirus infection
- Author
-
Claudia Colomba, Paola Di Carlo, Trizzino, M., Francesco Scarlata, Fasciana, Teresa Maria Assunta, Giammanco, Anna, Antonio Cascio, Colomba, C., DI CARLO, P., Trizzino, M., Scarlata, F., Fasciana, T., Giammanco, A., and Cascio, A.
- Subjects
acalculous cholecystitis, malaria, plasmodium falciparum, cytomegalovirus - Abstract
Acalculous cholecystitis is a syndrome of gallbladder inflammation without gallstones, recognized within the setting of critically ill patients. Acalculous cholecystitis associated with infectious agents is reported in the literature to be rare. Herein we describe a case of acalculous cholecystitis in a patient with malaria caused by Plasmodium falciparum and apparent cytomegalovirus infection, and discuss the possible role of CMV in the pathogenesis of acalculous cholecystitis in patients with malaria.
223. Norovirus and gastroenteritis in hospitalized children, Italy
- Author
-
Giovanni M. Giammanco, Claudia Colomba, Laura Saporito, Simona De Grazia, Lucina Titone, S. Ramirez, Serenella Arista, COLOMBA, C, SAPORITO, L, GIAMMANCO, G, DE GRAZIA, S, RAMIREZ, S, ARISTA, S, and TITONE LANZA DI SCALEA, L
- Subjects
Male ,Microbiology (medical) ,Settore MED/07 - Microbiologia E Microbiologia Clinica ,Settore MED/17 - Malattie Infettive ,Epidemiology ,genotype ,viruses ,norovirus ,lcsh:Medicine ,medicine.disease_cause ,lcsh:Infectious and parasitic diseases ,Enteritis ,fluids and secretions ,children ,Rotavirus ,Genotype ,Humans ,Medicine ,lcsh:RC109-216 ,enteritis ,Caliciviridae Infections ,business.industry ,lcsh:R ,Dispatch ,Infant ,virus diseases ,medicine.disease ,Virology ,digestive system diseases ,Gastroenteritis ,mixed infection ,Infectious Diseases ,Italy ,Norovirus ,Noroviruses, gastroenteritis ,Female ,business ,Mixed infection ,Viral enteritis - Abstract
Noroviruses were detected in 48.4% of 192 children (
224. First case of infant botulism in Sicily-case report.
- Author
-
Fazzino A, Cavallaro C, Cavataio F, Linares G, Lo Cascio A, Lo Porto C, Santangelo G, Venuti L, Corsello G, and Colomba C
- Subjects
- Humans, Sicily, Infant, Male, Botulinum Antitoxin therapeutic use, Clostridium botulinum isolation & purification, Female, Botulism diagnosis, Botulism therapy
- Abstract
Background: Botulism is a rare and life-threatening disease caused by the potent botulinum neurotoxin (BoNT), which can be produced by Clostridium botulinum (C. botulinum) and related bacteria. Clinical manifestations, which include a symmetrical, descending muscular paralysis, generalized hypotonia, and potentially respiratory failure, are non-specific and diagnosis is challenging, especially when anamnesis does not reveal any typical risk factor, like honey consumption., Case Presentation: We present what is, to the best of our knowledge, the first documented case of infant botulism (IB) in Sicily and discuss its peculiarities and the challenges faced in the diagnostic-therapeutic process. The infant was exclusively breastfed and no history of consumption of possibly contaminated foods, like honey, was found. The signs observed at presentation included poor suction, hypotonia, and hyporeactivity. A detailed anamnesis motivated the suspicion of botulism, due to the occurrence of constipation and exposure to dust from home renovation works during the days before the onset of symptoms. The botulinum antitoxin was administered and the diagnosis was confirmed through fecal examination, detecting toxin-producing C. botulinum., Conclusion: IB should be considered in every infant with rapidly progressing hypotonia and a history of constipation. However rarely, transmission could occur through inhalation of dust particles containing the toxin, therefore it is important to explore all possible sources of exposure. In the case described, timely diagnosis and treatment determined the successful outcome, which highlights the importance of early intervention in managing IB., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
225. Bacterial-like inflammatory response in children with adenovirus leads to inappropriate antibiotic use: a multicenter cohort study.
- Author
-
Moracas C, Poeta M, Grieco F, Tamborino A, Moriondo M, Stracuzzi M, Diana A, Petrarca L, Marra S, Licari A, Linsalata S, Albano C, Condemi A, Del Tufo E, Di Fraia T, Punzi L, Ardia E, Lo Vecchio A, Bruzzese E, Colomba C, Giacomet V, Midulla F, Marseglia GL, Galli L, and Guarino A
- Abstract
Purpose: To compare the clinical severity of Human Adenovirus (HAdV) infection with other viral diseases in a cohort of children, evaluating presentation, therapy, and outcome., Methods: We conducted a retrospective multicenter cohort study in Italian children hospitalized from January to December 2023 for respiratory symptoms. The study included children with HAdV infection presenting primarily with respiratory symptoms. Patients with isolated gastrointestinal involvement or coinfection with bacteria were excluded., Results: A total of 171 children were enrolled: 98 with HAdV infection (age 44.3 ± 37.9 months) and 73 with other viruses (age 20.4 ± 27.2 months). In the first group, 57.1% had a coinfection with one or more additional viruses. The most common symptoms were fever (89.8%), cough (73.5%) and sore throat (52%). Respiratory distress and hypoxemia were more frequent in the non-HAdV group. Children with HAdV infection demonstrated significantly higher C-reactive protein levels (50.8 ± 54.2 vs. 16.5 ± 33.8 mg/L, p < 0.001), experienced a longer duration of fever (4.9 ± 3.6 vs. 3.4 ± 2.3 days, p = 0.009) and were more likely to receive antibiotic treatment (77.6% vs. 27.4%, p < 0.001). No differences were observed in hospitalization stay, rate of complications, and ICU admission., Conclusions: Interestingly, our data suggests that HAdV-infected children exhibit a more pronounced inflammatory response despite experiencing less severe respiratory symptoms compared to other viruses. The presence of prolonged fever and a strong inflammatory response often leads to antibiotic overuse during the initial phase, when the viral etiology is yet to be confirmed. Early and accurate identification of HAdV infection is crucial to optimize treatment strategies and minimize unnecessary antibiotic use., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
226. The SpO 2 /FiO 2 Ratio Combined with Prognostic Scores for Pneumonia and COVID-19 Increases Their Accuracy in Predicting Mortality of COVID-19 Patients.
- Author
-
Zinna G, Pipitò L, Colomba C, Scichilone N, Licata A, Barbagallo M, Russo A, Coppola N, and Cascio A
- Abstract
Background: Identifying high-risk COVID-19 patients is critical for emergency department decision-making. Our study's primary objective was to identify new independent predictors of mortality and their predictive utility in combination with traditional pneumonia risk assessment scores and new risk scores for COVID-19 developed during the pandemic. Methods : A retrospective study was performed in two Italian University Hospitals. A multivariable logistic model was used to locate independent parameters associated with mortality. Results: Age, PaO
2 /FiO2 , and SpO2 /FiO2 ratios were found to be independent parameters associated with mortality. This study found that the Pneumonia Severity Index (PSI) was superior to many of the risk scores developed during the pandemic, for example, the International Severe Acute Respiratory Infection Consortium Coronavirus Clinical Characterisation Consortium (ISARIC 4C) (AUC 0.845 vs. 0.687, p < 0.001), and to many of the risk scores already in use, for example, the National Early Warning Score 2 (NEWS2) (AUC 0.845 vs. 0.589, p < 0.001). Furthermore, our study found that the Pneumonia Severity Index had a similar performance to other risk scores, such as CRB-65 (AUC 0.845 vs. 0.823, p = 0.294). Combining the PaO2 /FiO2 or SpO2 /FiO2 ratios with the risk scores analyzed improved the prognostic accuracy. Conclusions: Adding the SpO2 /FiO2 ratio to the traditional, validated, and already internationally known pre-pandemic prognostic scores seems to be a valid and rapid alternative to the need for developing new prognostic scores. Future research should focus on integrating these markers into existing pneumonia scores to improve their prognostic accuracy.- Published
- 2024
- Full Text
- View/download PDF
227. Therapeutic patient education and treatment intensification of diabetes and hypertension in subjects with newly diagnosed type 2 diabetes mellitus: a longitudinal study.
- Author
-
Coppola A, Chuquitaype M, Guglielmo S, Pujia R, Ferrulli A, Falcone C, Maurotti S, Montalcini T, Luzi L, and Gazzaruso C
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Longitudinal Studies, Hypoglycemic Agents therapeutic use, Prospective Studies, Adult, Glycated Hemoglobin analysis, Diabetes Mellitus, Type 2 therapy, Hypertension therapy, Hypertension drug therapy, Patient Education as Topic, Antihypertensive Agents therapeutic use
- Abstract
Purpose: The aim of this study is to prospectively evaluate whether individual and group Therapeutic Patient Education (TPE) can reduce the need to intensify treatment of diabetes and hypertension in newly diagnosed type 2 diabetic patients., Methods: A total of 937 patients were recruited and followed-up for 42.7 ± 21.5 months. TPE was a structured comprehensive education delivered by trained nurses: 322 patients received individual TPE (ITPE), 291 underwent group TPE (GTPE), and 324 were in Usual Care (UC). The primary endpoints were intensification of diabetes treatment and intensification of hypertension treatment., Results: The rate of diabetes treatment intensification was 40.1% in patients receiving ITPE, 47.8% in patients undergoing GTPE, and 64.2% in patients in UC (p < 0.001). The rate of hypertension treatment intensification was 24.2% in patients following ITPE, 31.3% in patients receiving GTPE, and 41.0% in patients in UC (p < 0.001). Multivariate analysis showed that both ITPE and GTPE were associated with reduced intensification of diabetes (ITPE: HR:0.51; 95% IC:0.40-0.64; p < 0.001 - GTPE: HR:0.46; 95% IC:0.44-0.70; p < 0.001) and hypertension medication (ITPE: HR:0.45; 95% IC:0.34-0.61; p < 0.001 - GTPE: HR:0.49; 95% IC:0.38-0.65; p < 0.001). The association was independent of age, sex, BMI, HbA1c, and presence of hypertension at baseline., Conclusions: TPE, delivered as both individual and group sessions, represents an effective tool to reduce the need to intensify treatment of both diabetes and hypertension. Therefore, it can ensure better control of diabetes and hypertension with fewer medications. This could reduce adverse effects and costs and improve quality of life and medication taking in patients with type 2 diabetes., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
228. Chromophore Optimization in Organometallic Au(III) Cys Arylation of Peptides and Proteins for 266 nm Photoactivation.
- Author
-
Silzel JW, Chen C, Sanchez-Marsetti C, Farias P, Carta V, Harman WH, and Julian RR
- Subjects
- Gold chemistry, Photochemical Processes, Proteins chemistry, Organogold Compounds chemistry, Humans, Cysteine chemistry, Peptides chemistry
- Abstract
Cysteine is the most reactive naturally occurring amino acid due to the presence of a free thiol, presenting a tantalizing handle for covalent modification of peptides/proteins. Although many mass spectrometry experiments could benefit from site-specific modification of Cys, the utility of direct arylation has not been thoroughly explored. Recently, Spokoyny and co-workers reported a Au(III) organometallic reagent that robustly arylates Cys and tolerates a wide variety of solvents and conditions. Given the chromophoric nature of aryl groups and the known susceptibility of carbon-sulfur bonds to photodissociation, we set out to identify an aryl group that could efficiently cleave Cys carbon-sulfur bonds at 266 nm. A streamlined workflow was developed to facilitate rapid examination of a large number of aryls with minimal sample using a simple test peptide, RAAACGVLK. We were able to identify several aryl groups that yield abundant homolytic photodissociation of the adjacent Cys carbon-sulfur bonds with short activation times (<10 ms). In addition, we characterized the radical products created by photodissociation by subjecting the product ions to further collisional activation. Finally, we tested Cys arylation with human hemoglobin, identified reaction conditions that facilitate efficient modification of intact proteins, and evaluated the photochemistry and activation of these large radical ions.
- Published
- 2024
- Full Text
- View/download PDF
229. Correction to: Therapeutic patient education and treatment intensification of diabetes and hypertension in subjects with newly diagnosed type 2 diabetes mellitus: a longitudinal study.
- Author
-
Coppola A, Chuquitaype M, Guglielmo S, Pujia R, Ferrulli A, Falcone C, Maurotti S, Montalcini T, Luzi L, and Gazzaruso C
- Published
- 2024
- Full Text
- View/download PDF
230. Hepatic fascioliasis: a rare case of "fake" biliary gallstones.
- Author
-
Amata M, Boncori G, Scimeca D, Mocciaro F, Bonaccorso A, Colomba C, and Di Mitri R
- Subjects
- Humans, Fascioliasis diagnosis, Fascioliasis diagnostic imaging, Gallstones complications, Gallstones diagnostic imaging, Biliary Tract
- Abstract
Competing Interests: The authors declare that they have no conflict of interest.
- Published
- 2024
- Full Text
- View/download PDF
231. Pertussis outbreak in neonates and young infants across Italy, January to May 2024: implications for vaccination strategies.
- Author
-
Poeta M, Moracas C, Albano C, Petrarca L, Maglione M, Pierri L, Carta M, Montaldo P, Venturini E, De Luca M, Buonsenso D, Brambilla I, Giacomet V, Lo Vecchio A, Bruzzese E, Midulla F, Colomba C, and Guarino A
- Subjects
- Humans, Italy epidemiology, Infant, Newborn, Infant, Female, Male, Pregnancy, Hospitalization statistics & numerical data, Whooping Cough prevention & control, Whooping Cough epidemiology, Disease Outbreaks prevention & control, Vaccination statistics & numerical data, Pertussis Vaccine administration & dosage, Bordetella pertussis immunology
- Abstract
Since January 2024, Italy experiences a pertussis outbreak, primarily affecting neonates and unvaccinated infants at high risk of severe complications and mortality; 11 major paediatric centres noted 108 hospitalisations and three deaths by 10 May. The outbreak reflects increased circulation of Bordetella pertussis and non-adherence to immunisation recommendations during pregnancy. Public health interventions, including maternal immunisation, vaccination of infants as early as possible and post-exposure prophylaxis, are critical for reducing the burden of pertussis and preventing further mortality.
- Published
- 2024
- Full Text
- View/download PDF
232. Dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in pediatric patients: a case series.
- Author
-
Garbo V, Condemi A, Albano C, Polara VF, Parrino R, Macaluso A, Venuti L, and Colomba C
- Abstract
Acute bacterial skin and skin-structure infections (ABSSSI) are a significant cause of morbidity in pediatric patients, requiring timely and effective treatment. Dalbavancin, a long-acting lipoglycopeptide antibiotic recently approved for pediatric use, offers advantages such as excellent bactericidal activity against Gram-positive bacteria (including multidrug-resistant pathogens) and high tissue penetration. We present a case series of pediatric patients with ABSSSI treated with dalbavancin. Five cases were described demonstrating the efficacy of dalbavancin in different clinical scenarios. Patients with complex skin conditions, including cellulitis and deep abscesses, benefited from dalbavancin therapy, achieving significant clinical improvement. Notably, dalbavancin facilitated early discharge, improving quality of life and reducing healthcare costs. These cases highlight the potential of dalbavancin as a valuable treatment option for ABSSSI in pediatric patients, particularly in settings where conventional therapies fail to achieve optimal clinical outcomes or prolonged hospitalization is not feasible. Further research is needed to clarify its role and optimize its use in pediatric patients with ABSSSI., Competing Interests: Conflict of interest: The authors declare no conflict of interest.
- Published
- 2024
- Full Text
- View/download PDF
233. COVID-19: The Development and Validation of a New Mortality Risk Score.
- Author
-
Zinna G, Pipitò L, Colomba C, Scichilone N, Licata A, Barbagallo M, Russo A, Almasio PL, Coppola N, and Cascio A
- Abstract
Background: The coronavirus disease 2019 (COVID-19) pandemic has found the whole world unprepared for its correct management. Italy was the first European country to experience the spread of the SARS-CoV-2 virus at the end of February 2020. As a result of hospital overcrowding, the quality of care delivered was not always optimal. A substantial number of patients admitted to non-ICU units could have been treated at home. It would have been extremely useful to have a score that, based on personal and clinical characteristics and simple blood tests, could have predicted with sufficient reliability the probability that a patient had or did not have a disease that could have led to their death. This study aims to develop a scoring system to identify which patients with COVID-19 are at high mortality risk upon hospital admission, to expedite and enhance clinical decision making. Methods : A retrospective analysis was performed to develop a multivariable prognostic prediction model. Results : Derivation and external validation cohorts were obtained from two Italian University Hospital databases, including 388 (10.31% deceased) and 1357 (7.68% deceased) patients with confirmed COVID-19, respectively. A multivariable logistic model was used to select seven variables associated with in-hospital death (age, baseline oxygen saturation, hemoglobin value, white blood cell count, percentage of neutrophils, platelet count, and creatinine value). Calibration and discrimination were satisfactory with a cumulative AUC for prediction mortality of 0.924 (95% CI: 0.893-0.944) in derivation cohorts and 0.808 (95% CI: 0.886-0.828) in external validation cohorts. The risk score obtained was compared with the ISARIC 4C Mortality Score, and with all the other most important scores considered so far, to evaluate the risk of death of patients with COVID-19. It performed better than all the above scores to evaluate the predictability of dying. Its sensitivity, specificity, and AUC were higher than the other COVID-19 scoring systems when the latter were calculated for the 388 patients in our derivation cohort. Conclusions : In conclusion, the CZ-COVID-19 Score may help all physicians by identifying those COVID-19 patients who require more attention to provide better therapeutic regimens or, on the contrary, by identifying those patients for whom hospitalization is not necessary and who could therefore be sent home without overcrowding healthcare facilities. We developed and validated a new risk score based on seven variables for upon-hospital admission of COVID-19 patients. It is very simple to calculate and performs better than all the other similar scores to evaluate the predictability of dying.
- Published
- 2024
- Full Text
- View/download PDF
234. Demineralization Pretreatments for Reducing Biomass Variability in Pyrolysis.
- Author
-
Branca C and Di Blasi C
- Abstract
Thermogravimetric and calorimetric analyses are applied to study how washing modifies the pyrolysis rates and heats of five samples of potato plant stems. Hot (553 K) water or dilute (hydrochloric) acid washing of powdered samples causes a reduction in the alkali content by about 62-78 or 97-99%. The feedstock variability is highly reduced, especially for dilute acid treatment. The char yields drastically decrease up to 42-50%, with increases in the peak rates and corresponding temperatures of up to 20-60% and 50-60 K, respectively. Overall, these characteristic parameters closely approach the beech wood values used for comparison. The shape of the rate curves also testifies the dissolution of nonstructural organic components (pectin, starch, and protein) essentially to the advantage of holocellulose. The ratios between activation energy and order of the global devolatilization reaction increase from about 62-98 kJ/mol (no treatment) to 78-104 kJ/mol (hot water) and 113-124 kJ/mol (dilute acid) (versus 141 kJ/mol for wood). Following washing, the strong exothermic character of the crop residues (global reaction heats from -560 to -180 J/g) is lost. The pyrolysis becomes nearly thermally neutral after hot water washing (heats from -106 to -25 J/g). Furthermore, dilute acid washing makes the process shift from exothermic to endothermic with heats around 70-270 J/g (versus 238 J/g of wood)., Competing Interests: The authors declare no competing financial interest., (© 2024 The Authors. Published by American Chemical Society.)
- Published
- 2024
- Full Text
- View/download PDF
235. Tuberculous Pericarditis in Childhood: A Case Report and a Systematic Literature Review.
- Author
-
Venuti L, Condemi A, Albano C, Boncori G, Garbo V, Bagarello S, Cascio A, and Colomba C
- Abstract
Tuberculous pericarditis (TBP) is an important cause of pericarditis worldwide while being infrequent in childhood, especially in low-TB-incidence countries. We report a case of TBP and provide a systematic review of the literature, conducted by searching PubMed, Scopus, and Cochrane to find cases of TBP in pediatric age published in the English language between the year 1990 and the time of the search. Of the 587 search results obtained, after screening and a backward citation search, 45 studies were selected to be included in this review, accounting for a total of 125 patients. The main signs and symptoms were fever, cough, weight loss, hepatomegaly, dyspnea, and increased jugular venous pressure or jugular vein turgor. A definitive diagnosis of TBP was made in 36 patients, either thanks to microbiological investigations, histological analysis, or both. First-line antitubercular treatment (ATT) was administered in nearly all cases, and 69 children underwent surgical procedures. Only six patients died, and only two died of TBP. TBP in childhood is relatively uncommon, even in high-TB-prevalence countries. Clinical manifestations, often suggestive of right-sided cardiac failure, are subtle, and diagnosis is challenging. TBP has an excellent prognosis in childhood; however, in a significant proportion of cases, invasive surgical procedures are necessary.
- Published
- 2024
- Full Text
- View/download PDF
236. Real-World Use of Dalbavancin for Treatment of Soft Tissue and Bone Infection in Children: Safe, Effective and Hospital-Time Sparing.
- Author
-
Caselli D, Mariani M, Colomba C, Ferrecchi C, Cafagno C, Trotta D, Carloni I, Dibello D, Castagnola E, and Aricò M
- Abstract
Acute bacterial skin and skin structure infections (ABSSSI) and osteoarticular infections compound the burden of morbidity, mortality and prolonged hospitalizations among gram-positive infections. Dalbavancin, a second-generation, intravenous lipoglycopeptide, due to its prolonged half-life, can be a valuable alternative in their treatment when administered as inpatient treatment at the price of an extended hospital stay. Between October 2019 and September 2023, 31 children and adolescents were treated with dalbavancin because of bone and joint infections (n = 12 patients, 39%), ABSSSI (n = 13 patients, 42%), mainly for the limbs, facial cellulitis or complicated ABSSSI (n = 6 patients, 19%), at five Italian pediatric centers. Microbiological study provided gram-positive bacterial isolate in 16 cases, in 11 cases from a positive blood culture; 9 of them were MRSA. Twenty-five patients were initially treated with a different antibiotic therapy: beta-lactam-based in 18 patients (58%), glycopeptide-based in 15 patients (48%) and daptomycin in 6 (19%). The median time that elapsed between admission and start of dalbavancin was 18 days. A total of 61 doses of dalbavancin were administered to the 31 patients: 16 received a single dose while the remaining 15 patients received between two (n = 9) and nine doses. The frequency of administration was weekly in five cases or fortnightly in nine patients. Median length of stay in hospital was 16 days. Median time to discharge after the first dose of dalbavancin was 1 day. Treatment was very well-tolerated: of the 61 administered doses, only four doses, administered to four patients, were associated with an adverse event: drug extravasation during intravenous administration occurred in two patients, with no sequelae; however, in two patients the first administration was stopped soon after infusion start: in one (ID #11), due to headache and vomiting; in another (ID #12) due to a systemic reaction. In both patients, drug infusion was not repeated. None of the remaining 29 patients reported treatment failure (resistant or recurrent disease) or an adverse effect during a median follow-up time of two months. The use of dalbavancin was safe, feasible and also effective in shortening the hospital stay in children and adolescents.
- Published
- 2024
- Full Text
- View/download PDF
237. Imported cutaneous myiasis in a child and her father.
- Author
-
Albano C, Linares G, Garbo V, Stancampiano S, Giordano S, and Colomba C
- Subjects
- Humans, Animals, Female, Child, Male, Fathers, Larva, Myiasis diagnosis, Diptera
- Abstract
Competing Interests: Declaration of competing interest Nothing to declare.
- Published
- 2023
- Full Text
- View/download PDF
238. Causes of hospitalization and predictors of in-hospital mortality among people living with HIV in Sicily-Italy between 2010 and 2021.
- Author
-
Pipitò L, Zinna G, Trizzino M, Gioè C, Tolomeo M, Di Carlo P, Colomba C, Gibaldi L, Iaria C, Almasio P, and Cascio A
- Abstract
Background: Despite the rising number of people living with human immunodeficiency virus (HIV), there is a lack of knowledge about the factors that lead to PLWHs being hospitalized in worldwide literature. Our study aimed to investigate PLWH admissions in Sicily (Italy) between January 2010 and September 2021 and to analyze the characteristics and risk factors for in-hospital mortality and differences between Italians and foreigners., Methods: Data from the hospital discharge forms of all people living with HIV (PLWH) hospitalized in Sicilian hospitals were retrospectively collected. Age, sex, nationality, length of stay, acquired immunodeficiency syndrome (AIDS), and non-AIDS-related diseases were evaluated using univariate analysis according to in-hospital mortality rates. The factors associated with mortality were included in the logistic regression model., Results: In total, 5281 admissions from 2726 PLWHs occurred, most of which were related to non-AIDS diseases. Approximately 20 % regarded foreign patients, mainly from Africa. Logistic regression analysis revealed an association between in-hospital mortality and some AIDS- and non-AIDS-related diseases (wasting syndrome, lymphomas, Kaposi sarcomas, progressive multifocal leukoencephalopathy, cryptococcosis, abscesses, sepsis, cardiovascular disease, nephropathy, and respiratory diseases). African patient admissions were significantly associated with tuberculosis, toxoplasmosis, Burkitt lymphoma, and hepatitis B diagnoses., Conclusions: Our study showed that most hospitalizations were related to non-AIDS-defining diseases, with differences between Italian and foreign patients, mainly from Africa., Competing Interests: Declaration of Competing Interest We have no conflict of interest to declare., (Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
239. Imported malaria in pregnancy in Europe: A systematic review of the literature of the last 25 years.
- Author
-
Guida Marascia F, Colomba C, Abbott M, Gizzi A, Anastasia A, Pipitò L, and Cascio A
- Subjects
- Child, Female, Pregnancy, Infant, Newborn, Humans, Pregnancy Outcome, Europe epidemiology, Malaria diagnosis, Malaria epidemiology, Malaria complications, Malaria, Falciparum complications, Malaria, Vivax, Anemia
- Abstract
Background: Malaria during pregnancy is associated with a greater risk of complications for the mother and fetus. The aim of the study is to analyze the features of imported cases of malaria in pregnant women in Europe and evaluate which factors are associated with a non-favourable outcome., Methods: A computerized search of the literature was performed combining the terms plasmod*, malaria, pregnan*, maternal, gravid, parturient, expectant, and congenital, from January 1997 to July 2023., Results: 28 articles reporting 57 cases of malaria in pregnant women immigrant in non-endemic areas were included. The patients mainly came from Sub-Saharan Africa. There were 10 asymptomatic cases, while the predominant clinical syndrome among the symptomatic women was fever associated with anaemia. The median latency period from permanence in endemic areas and diagnosis in European countries was 180 days (IQR 15-730). Pregnancy outcomes were favourable in 35 cases (61 %): all term pregnancies, no low-birth-weight newborns. There were 4 abortions; 1 child was delivered pre-term; 7 babies were reported to have a low birth weight; 10 cases of congenital malaria were documented. P. falciparum was found with a higher frequency in women with a favourable outcome, while P. vivax was, in all cases, associated with a worse prognosis., Conclusions: Diagnosis of malaria in pregnant woman in non-endemic countries may be challenging and a delay in diagnosis may lead to an adverse outcome. Screening for malaria should be performed in pregnant women from endemic areas, especially if they present anaemia or fever., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
240. Mucosal Relapse of Visceral Leishmaniasis in a Child with SARS-CoV-2 Infection.
- Author
-
Colomba C, Boncori G, Albano C, Garbo V, Bagarello S, Condemi A, Giordano S, and Cascio A
- Abstract
Leishmaniasis is a vector-borne disease caused by protozoan parasites of the genus Leishmania and is transmitted through the bite of infected female sandflies. In the Mediterranean region, visceral leishmaniasis is caused by Leishmania. infantum, and it is usually responsible for symptoms such as fever, pancytopenia and enlargement of the liver and spleen. Relapse is rare in immunocompetent patients as much as the mucous involvement. We present a rare case of mucosal relapse of visceral leishmaniasis in a child with SARS-CoV-2 infection and perform an extensive review of the literature about leishmaniasis relapses in children. Atypical mucosal involvement during Leishmaniasis relapse is an eventuality in pediatric patients. Clinical follow-up and periodic PCR tests must be considered essential for the early recognition and treatment of an eventual relapse.
- Published
- 2023
- Full Text
- View/download PDF
241. Hospitalizations for tuberculosis in Sicily over the years 2009-2021: Clinical features, comorbidities, and predictors of mortality.
- Author
-
Pipitò L, Colomba C, Mancuso A, Catania B, Cuccia A, Sergio M, Iaria C, and Cascio A
- Subjects
- Humans, Retrospective Studies, Sicily epidemiology, Hospitalization, Hospital Mortality, HIV Infections, Tuberculosis epidemiology
- Abstract
Background: Very few data are available in the literature regarding tuberculosis (TB) hospitalization, and few studies have reported the clinical characteristics and comorbidities of admitted patients and burden and cost of hospitalization. In our study, we described the occurrence of TB hospital admissions in the southern Italian region of Sicily over 13 years (2009-2021), explored the characteristics of patients with TB, and determined the comorbidities associated with mortality., Method: Data on the hospital discharge of all patients with TB hospitalized in all Sicilian hospitals were retrospectively collected from hospital standard discharge forms. Age, sex, nationality, length of hospital stay, comorbidities, and TB localization were evaluated using univariate analysis according to in-hospital mortality. The factors associated with mortality were included in the logistic regression model., Results: In Sicily, 3745 people were hospitalized for TB, with 5239 admissions and 166 deaths from 2009 to 2021. Most hospitalizations involved Italian-born people (46.3%), followed by African-born people (32.8%) and Eastern European-born people (14.1%). The average hospitalization cost was EUR 5259 ± 2592, with a median length of stay of 16 days (interquartile range, 8-30) days. Multivariate analysis showed that the development of acute kidney failure (adjusted odds ratio [aOR]=7.2, p < 0.001), alcohol consumption (aOR=8.9, p = 0.001), malignant tumors (aOR=2.1, p = 0.022), human immunodeficiency virus infection (aOR=3.4, p < 0.001), sepsis (aOR=15.2, p < 0.001), central nervous system involvement (aOR=9.9, p < 0.001), and miliary TB (aOR=2.5, p = 0.004) were independent predictors of mortality., Conclusion: TB in Sicily remains an important cause of hospitalization. HIV infection and comorbidities may complicate patient management and worsen patient outcomes., Competing Interests: Declaration of Competing Interest We have no conflict of interest to declare., (Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
242. Fever with spontaneous gingival bleeding: A diagnostic challenge.
- Author
-
Colomba C, Albano C, Boncori G, Condemi A, and Cascio A
- Subjects
- Humans, Gingival Hemorrhage diagnosis, Fever
- Abstract
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
- Published
- 2023
- Full Text
- View/download PDF
243. Streptococcus mitis as a New Emerging Pathogen in Pediatric Age: Case Report and Systematic Review.
- Author
-
Colomba C, Garbo V, Boncori G, Albano C, Bagarello S, Condemi A, Giordano S, Canduscio LA, Gallo C, Parrinello G, and Cascio A
- Abstract
Streptococcus mitis , a normal inhabitant of the oral cavity, is a member of Viridans Group Streptococci (VGS). Generally recognized as a causative agent of invasive diseases in immunocompromised patients, S. mitis is considered to have low pathogenic potential in immunocompetent individuals. We present a rare case of sinusitis complicated by meningitis and cerebral sino-venous thrombosis (CSVT) caused by S. mitis in a previously healthy 12-year-old boy with poor oral health status. With the aim of understanding the real pathogenic role of this microorganism, an extensive review of the literature about invasive diseases due to S. mitis in pediatric patients was performed. Our data define the critical role of this microorganism in invasive infections, especially in immunocompetent children and in the presence of apparently harmful conditions such as sinusitis and caries. Attention should be paid to the choice of therapy because of VGS's emerging antimicrobial resistance patterns.
- Published
- 2023
- Full Text
- View/download PDF
244. The Use of Intravenous Fosfomycin in Clinical Practice: A 5-Year Retrospective Study in a Tertiary Hospital in Italy.
- Author
-
Anastasia A, Bonura S, Rubino R, Giammanco GM, Miccichè I, Di Pace MR, Colomba C, and Cascio A
- Abstract
Fosfomycin in intravenous (IV) formulation has re-emerged as a valuable tool in the treatment of multi-drug resistant (MDR) and extensively drug-resistant (XDR) infections because of its broad spectrum of antibacterial action and pharmacokinetic characteristics. This retrospective study aimed to evaluate how fosfomycin was used in patients admitted to the Polyclinic of Palermo between January 2017 and July 2022. Clinical indications, therapeutic associations, clinical outcomes, and any side effects were analyzed. Intravenous fosfomycin was used in 343 patients, 63% male, with a mean age of 68 years (range 15-95). Urinary tract infections (UTIs) and hospital-acquired pneumonia (HAP) were the main indications for treatment (19% and 18% of the total cases, respectively), followed by skin and soft tissue infections and sepsis. IV fosfomycin was administered in combination with other antibacterial agents, the most common of which were ceftazidime/avibactam (35%), meropenem (17%), and colistin (14%). Nineteen patients received it as monotherapy for UTIs. About 66% had resolution of the infectious process with clinical remission (cure or discharge). Electrolyte disturbances occurred in 2.6% and gastrointestinal symptoms occurred in 2.9%. The data showed that IV fosfomycin is a safe and effective therapeutic option in the treatment of infections with multidrug-resistant microorganisms.
- Published
- 2023
- Full Text
- View/download PDF
245. COVID-19 and neurological disorders: what might connect Parkinson's disease to SARS-CoV-2 infection.
- Author
-
Iacono S, Schirò G, Davì C, Mastrilli S, Abbott M, Guajana F, Arnao V, Aridon P, Ragonese P, Gagliardo C, Colomba C, Scichilone N, and D'Amelio M
- Abstract
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- Published
- 2023
- Full Text
- View/download PDF
246. A case of syphilis associated with immune reconstitution inflammatory syndrome and review of the literature.
- Author
-
Pipitò L, Medaglia AA, Trizzino M, Bonura S, Gioè C, Di Carlo P, Colomba C, and Cascio A
- Subjects
- Humans, Male, Adult, HIV Infections complications, HIV Infections drug therapy, Syphilis diagnosis, Syphilis drug therapy, Immune Reconstitution Inflammatory Syndrome diagnosis, Immune Reconstitution Inflammatory Syndrome etiology
- Abstract
Background: Immune reconstitution inflammatory syndrome (IRIS) associated with syphilis has rarely been described in HIV-infected patients. Diagnosis can be challenging because it is not always possible to discern it from a recent infection or a worsening of an undiagnosed one., Case Presentation: An HIV-positive 42-year-old man with a poor compliance history of antiretroviral therapy presented at our unit and complained of ocular symptoms. Ocular syphilis diagnosis was posed after initial misdiagnosing with cytomegalovirus infection, and antiretroviral therapy compliance improved after switching to a bictegravir-based regimen. Despite intravenous (IV) penicillin, we observed an initial worsening with the appearance of new skin lesions, and IRIS syphilis was suspected. In the literature, 14 cases of IRIS syphilis are described, all regarding male patients. Seven were HIV naïve to therapy, and 7 HIV-experienced with poor therapy compliance. Basal syphilis serology was negative in ten, with subsequent seroconversion after the development of IRIS. IRIS-syphilis development was observed after a median time of 28 days from ART initiation; 10 cases were considered "unmasking-IRIS" and 4 "paradoxical-IRIS". Skin and ocular involvement were the most often reported. In most cases, it was not necessary to use a systemic steroid. A good outcome was reported in 12., Conclusions: Syphilis should be considered in differential diagnosis with other diseases associated with IRIS. A negative syphilis serology before beginning antiretroviral therapy could convey the impression that syphilis has been ruled out. Whereas a high index of suspicion should be maintained when symptoms suggestive of syphilis, such as ocular and skin manifestations, are noticed after therapy has begun., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
247. Clostridioides difficile Infection in an Italian Tertiary Care University Hospital: A Retrospective Analysis.
- Author
-
Medaglia AA, Mancuso A, Albano C, Zinna G, Pipitò L, Calà C, Immordino R, Rubino R, Bonura S, Canino B, Calamusa G, Colomba C, Almasio PL, and Cascio A
- Abstract
Clostridioides difficile infection (CDI) is a significant cause of morbidity and mortality, mostly in frail patients. Notification is not mandatory in Italy, and data on incidence, risk of death, and recurrence are lacking. The purpose of this study was to determine CDI incidence and risk factors for mortality and recurrence. The "ICD-9 00845" code in hospital-standardized discharged forms (H-SDF) and microbiology datasets were used to retrieve CDI cases at Policlinico Hospital, Palermo between 2013 and 2022. Incidence, ward distribution, recurrence rate, mortality, and coding rate were considered. The risk of death and recurrence was predicted through multivariable analysis. There were 275 CDIs, 75% hospital-acquired, the median time between admission and diagnosis was 13 days, and the median stay was 21 days. Incidence increased from 0.3 to 5.6% (an 18.7-fold increase) throughout the decade. Only 48.1% of cases were coded in H-SDF. The rate of severe/severe-complicated cases increased 1.9 times. Fidaxomicin was used in 17.1% and 24.7% of cases overall and since 2019. Overall and attributable mortalities were 11.3% and 4.7%, respectively. Median time between diagnosis and death was 11 days, and recurrence rate was 4%. Bezlotoxumab was administered in 64% of recurrences. Multivariable analysis revealed that only hemodialysis was associated with mortality. No statistically significant association in predicting recurrence risk emerged. We advocate for CDI notification to become mandatory and recommend coding CDI diagnosis in H-SDF to aid in infection rate monitoring. Maximum attention should be paid to preventing people on hemodialysis from getting CDI.
- Published
- 2023
- Full Text
- View/download PDF
248. Rickettsiales in the WHO European Region: an update from a One Health perspective.
- Author
-
Guccione C, Colomba C, Iaria C, and Cascio A
- Subjects
- Animals, Humans, Rickettsiales, World Health Organization, One Health, Rickettsia genetics, Rickettsia Infections microbiology, Ticks microbiology
- Abstract
Background: The availability of molecular techniques has significantly increased our understanding of bacteria of the order Rickettsiales, allowing the identification of distinct species in both vector and host arthropods. However, the literature lacks studies that comprehensively summarize the vast amount of knowledge generated on this topic in recent years. The purpose of this study was to conduct a comprehensive analysis of the distribution of Rickettsiales in arthropod vectors, animals and humans in the WHO European Region in order to provide useful information to predict the emergence of certain diseases in specific geographical areas and to formulate hypotheses regarding the possible pathogenetic role of some rickettsial species in the etiology of human pathological conditions., Methods: A systematic review of the literature in the PubMed and EMBASE databases was conducted following the PRISMA methodology using the search terms "Spotted fever" OR "rickettsiosis" OR "ricketts*" AND all the countries of the WHO European Region, from 1 January 2013 to 12 February 2022. Only studies that identified rickettsiae in human, animal or arthropod samples using molecular techniques were included in the review., Results: A total of 467 articles considering 61 different species of Rickettsiales with confirmed or suspected human pathogenicity were analyzed in the review. More than 566 identifications of Rickettsiales DNA in human samples were described, of which 89 cases were assessed as importation cases. A total of 55 species of ticks, 17 species of fleas, 10 species of mite and four species of lice were found infected. Twenty-three species of Rickettsiales were detected in wild and domestic animal samples., Conclusion: The routine use of molecular methods to search for Rickettsiales DNA in questing ticks and other blood-sucking arthropods that commonly bite humans should be encouraged. Molecular methods specific for Rickettsiales should be used routinely in the diagnostics of fever of unknown origin and in all cases of human diseases secondary to an arthropod bite or animal contact., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
249. GM Allotypes and COVID-19. A Pilot Study Performed on Sicilian Patients.
- Author
-
Ligotti ME, Calabrò A, Accardi G, Aiello A, Caruso C, Colomba C, Di Bona D, Duro G, Namboodiri AM, Tuttolomondo A, Pandey JP, and Candore G
- Abstract
Several studies suggest that genetic variants that influence the onset, maintenance and resolution of the immune response might be fundamental in predicting the evolution of COVID-19. In the present paper, we analysed the distribution of GM allotypes (the genetic markers of immunoglobulin γ chains) in symptomatic and asymptomatic COVID-19 patients and in healthy controls, all born and residing in Sicily. Indeed, the role played by GM allotypes in immune responses and infection control is well known. Our findings show that the GM23 allotype is significantly reduced in healthy controls. Interestingly, in a previous study, Sicilians carrying the GM23 allotype were associated with the risk of developing a symptomatic Human Cytomegalovirus infection. However, a note of caution should be considered, due to the small sample size of patients and controls., Competing Interests: Conflict of interest No conflict of interest., (© 2022 Università di Salerno.)
- Published
- 2022
- Full Text
- View/download PDF
250. IL-1 Superfamily Member ( IL-1A , IL-1B and IL-18 ) Genetic Variants Influence Susceptibility and Clinical Course of Mediterranean Spotter Fever.
- Author
-
Scola L, Pilato G, Giarratana RM, Sanfilippo GL, Lio D, Colomba C, and Giammanco GM
- Subjects
- Humans, Disease Progression, Gene Frequency, Genotype, Interleukin-18 genetics, Interleukin-1alpha genetics, Interleukin-1beta genetics, Boutonneuse Fever genetics
- Abstract
Mediterranean Spotted Fever (MSF) is one of the most common spotted fever Rickettsioses. Most cases of MSF follow a benign course, with a minority of cases being fatal. The severity of the infection depends on bacterial virulence, dose and host factors such as effective immune response and genetic background. Herein, we reported data on typing by competitive allele-specific PCR of functionally relevant polymorphisms of genes coding for MyD88 adapter-like ( Mal/TIRAP ) protein ( rs8177374 ), interleukin(IL)-1 cluster ( IL-1A rs1800587 , IL-1B rs16944 and rs1143634 ) and IL-18 ( rs187238 ), which might be crucial for an efficient immune response. The results enlighten the role that IL-1 gene cluster variants might play in susceptibility against Rickettsia conorii infection. In particular, the IL-1A rs1800587TT genotype was significantly increased in patients alone and combined in a haplotype composed by minor alleles rs1800587T , rs16944A and rs1143634A . This result was confirmed using the decision tree heuristic approach. Using this methodology, IL-1A rs1800587TT genotype was the better discrimination key among MSF patients and controls. In addition, the IL-1 gene cluster SNP genotypes containing minor alleles and IL-18 rs187238G positive genotypes were found as associated with risk of severe complications such as sepsis, septic shock, acute respiratory distress syndrome and coma. In conclusion, these data suggest that the evaluation of IL-1A , IL-1B and IL-18 gene SNPs can add useful information on the clinical course of patients affected by Mediterranean Spotted Fever, even if further confirmatory studies will be necessary.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.